Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

0ACX

Centessa Pharmaceuticals (0ACX)

Centessa Pharmaceuticals Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0ACX
DateTimeSourceHeadlineSymbolCompany
12/11/202423:00UK RegulatoryCentessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business UpdateLSE:0ACXCentessa Pharmaceuticals Plc
13/09/202412:34UK RegulatoryCentessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary SharesLSE:0ACXCentessa Pharmaceuticals Plc
12/09/202406:04UK RegulatoryCentessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary SharesLSE:0ACXCentessa Pharmaceuticals Plc
10/09/202421:00UK RegulatoryCentessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy VolunteersLSE:0ACXCentessa Pharmaceuticals Plc
27/08/202422:00UK RegulatoryCentessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)LSE:0ACXCentessa Pharmaceuticals Plc
13/08/202421:00UK RegulatoryCentessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024LSE:0ACXCentessa Pharmaceuticals Plc
 Showing the most relevant articles for your search:LSE:0ACX